Nebenwirkungen · Samsca
Samsca 7.5 mg tablets Samsca 15 mg tablets Samsca 30 mg tablets · Abschnitt 4.8 · PDF-Seite 8–9
HOS-209953 · Präparat HOS-154407
8 System Organ Frequency Class Very common Common Uncommon Not known Acute hepatic failure3 Investigations Blood urine Bilirubin Elevated present1, increased (see transaminases2 Alanine section 4.4)1 aminotransferase increased (see section 4.4)1, Aspartate aminotransferase increased (see section 4.4)1, Blood creatinine increased Surgical and Rapid correction medical of hyponatremia, procedures sometimes leading to neurological symptoms 1 observed in clinical trials investigating other indications 2 from post-authorisation safety study in hyponatremia secondary to SIADH 3 observed in post-marketing with tolvaptan in ADPKD. Liver transplantation was necessary.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2026-08-20T16:11:00Z · SHA-256 5574073b9385d0a0abc476040d23f65049ec17111a8b63f2d4c4c0ac68807fc8 · Passage 52ed6c9972ef14ab592345c58e762abe170bf02373af6e79edd93c99525cc806 · Zeichen 3103–4743 im Abschnitt